Copyright: ©Author(s) 2026.
World J Diabetes. Jul 15, 2026; 17(7): 120647
Published online Jul 15, 2026. doi: 10.4239/wjd.120647
Published online Jul 15, 2026. doi: 10.4239/wjd.120647
Figure 4 Subgroup analysis of C-reactive protein-triglyceride-glucose index-metabolic dysfunction–associated steatotic liver disease associations.
MASLD: Metabolic dysfunction-associated steatotic liver disease.
- Citation: Zhang WH, Shi RDQ, Chen K, Li XM, Yu GH, Ye XY, Xu Q, Ding Y, Luo SH. Association between the high-sensitivity C-reactive protein-triglyceride-glucose index and metabolic dysfunction-associated steatotic liver disease across different glycemic states. World J Diabetes 2026; 17(7): 120647
- URL: https://www.wjgnet.com/1948-9358/full/v17/i7/120647.htm
- DOI: https://dx.doi.org/10.4239/wjd.120647